The appropriate dosing regimen of specific beta-lactam antibiotics in people with CF.

Differentiate between full telemedicine and limited contact care, or hybrid telemedicine. Identify which patients may benefit from telemedicine-based care.

How does CFTR modulators affect liver tests and CF liver disease.

the effects of triple combination CFTR modulator therapy for people with at least one copy of the F508del CFTR mutation.

The options for treating depression and anxiety in adults with cystic fibrosis.

The potential benefits and risks, as reported in phase 2 studies, of triple combination CFTR modulator therapy.

Selected patient populations that may benefit from the addition of a second inhaled antibiotic and currently used regimens of continuous alternating therapy with multiple inhaled antibiotics.

The findings that explain the cause of weight gain in patients with CF taking ivacaftor and how exocrine pancreatic functions may be improved with ivacaftor treatment.

Volume 8, Issue 7. Part 3

Volume 8, Issue 7. Part 2